Michael Leapman, MD

Yale University School of Medicine

Dr Michael Leapman is a urologic oncologist who practices at Yale University School of Medicine. His clinical and research interests center in the diagnosis, counseling, and surgical treatment of patients with prostate cancer. Dr. Leapman graduated from Cornell University where he majored in Neurobiology and Behavior, and received his medical school degree from the University of Maryland in Baltimore. He completed his General Surgery and Urology training at the Mount Sinai Hospital in New York, NY. Subsequently, he completed a urologic oncology fellowship at the University of California San Francisco (UCSF) accredited by the Society of Urologic Oncology.

Disclosure information not submitted.

Presentation(s):

• MP17-02: Association between the Decipher genomic classifier and prostate cancer outcome in a large-scale real-world dataset

  Friday, April 28, 2023
  1:00 PM – 3:00 PM CST

• MP17-09: Development of a Longitudinal Prostate Cancer Transcriptomic and Real-World Clinical Data Linkage

  Friday, April 28, 2023
  1:00 PM – 3:00 PM CST

• PD10-01: Associations between prostate MRI and genomic testing and treatment intensification among patients with localized prostate cancer

  Friday, April 28, 2023
  3:30 PM – 3:40 PM CST

• MP75-01: Association Between Sociodemographic Factors and Diagnosis of Advanced Prostate Cancer in Early Life

  Monday, May 1, 2023
  9:30 AM – 11:30 AM CST